147
Participants
Start Date
April 30, 2006
Primary Completion Date
September 30, 2007
Study Completion Date
April 30, 2010
adalimumab
Adalimumab 40 mg every other week, subcutaneous
adalimumab
Adalimumab 80 mg every other week, subcutaneous
Site Ref # / Investigator 5491, Bunkyō City
Site Ref # / Investigator 5429, Chiyoda-ku
Site Ref # / Investigator 5464, Fukuoka
Site Ref # / Investigator 5477, Fukuoka
Site Ref # / Investigator 5492, Fukuoka
Site Ref # / Investigator 5504, Fukuoka
Site Ref # / Investigator 5400, Fukushima
Site Ref # / Investigator 5406, Fukushima
Site Ref # / Investigator 5407, Fukushima
Site Ref # / Investigator 5437, Fukushima
Site Ref # / Investigator 5401, Gifu
Site Ref # / Investigator 5434, Gifu
Site Ref # / Investigator 5408, Hamamatsu
Site Ref # / Investigator 5495, Hiroshima
Site Ref # / Investigator 5391, Hokkaido
Site Ref # / Investigator 5402, Ishikawa
Site Ref # / Investigator 5431, Itabashi-ku
Site Ref # / Investigator 5462, Kagoshima
Site Ref # / Investigator 5476, Kagoshima
Site Ref # / Investigator 5435, Kanagawa
Site Ref # / Investigator 5432, Kawachi-gun
Site Ref # / Investigator 5440, Kawasaki
Site Ref # / Investigator 5499, Kyoto
Site Ref # / Investigator 5503, Kyoto
Site Ref # / Investigator 5411, Minatoku
Site Ref # / Investigator 5404, Mitaka
Site Ref # / Investigator 5417, Miyagi
Site Ref # / Investigator 5463, Nagasaki
Site Ref # / Investigator 5427, Nagoya
Site Ref # / Investigator 5465, Nankoku
Site Ref # / Investigator 5493, Nankoku
Site Ref # / Investigator 5482, Nishinomiya
Site Ref # / Investigator 5395, Numakunai
Site Ref # / Investigator 5496, Okayama
Site Ref # / Investigator 5441, Osaka
Site Ref # / Investigator 5467, Osaka
Site Ref # / Investigator 5480, Osaka
Site Ref # / Investigator 5483, Osaka
Site Ref # / Investigator 5498, Osaka
Site Ref # / Investigator 5388, Sapporo
Site Ref # / Investigator 5396, Sapporo
Site Ref # / Investigator 5399, Sapporo
Site Ref # / Investigator 5414, Shinjuku-ku
Site Ref # / Investigator 5433, Shizuoka
Site Ref # / Investigator 5466, Suita
Site Ref # / Investigator 5497, Suita
Site Ref # / Investigator 5505, Suita
Site Ref # / Investigator 5481, Tokushima
Site Ref # / Investigator 5506, Tokushima
Site Ref # / Investigator 6918, Tokushima
Site Ref # / Investigator 5405, Tokyo
Site Ref # / Investigator 5409, Tokyo
Site Ref # / Investigator 5410, Tokyo
Site Ref # / Investigator 5412, Tokyo
Site Ref # / Investigator 5413, Tokyo
Site Ref # / Investigator 5430, Tokyo
Site Ref # / Investigator 6553, Tokyo
Site Ref # / Investigator 5468, Tsu
Site Ref # / Investigator 5475, Ube
Site Ref # / Investigator 5415, Urayasu
Site Ref # / Investigator 5438, Urayasu
Site Ref # / Investigator 5416, Yamagata
Site Ref # / Investigator 5403, Yokohama
Site Ref # / Investigator 5428, Yokohama
Lead Sponsor
Abbott Japan Co.,Ltd
INDUSTRY
Eisai Co., Ltd.
INDUSTRY
Abbott
INDUSTRY